Bio
Jennifer Rose-Nussbaumer is a board-certified ophthalmologist and fellowship-trained cornea specialist at the Byers Eye Institute at Stanford University. Her clinical practice focuses on lamellar keratoplasty such as Descemet Membrane Endothelial Keratoplasty (DMEK), Ultrathin-Descemet Stripping Automated Endothelial Keratoplasty (UT-DSAEK), and Deep Anterior Lamellar Keratoplasty (DALK), as well as cataract surgery. After completing her fellowship in corneal transplantation at the University of California, San Francisco, she stayed on faculty and remained there until she transitioned to Stanford in 2021.
In addition to her clinical work, Dr. Rose-Nussbaumer is an NIH-funded researcher who focuses on randomized clinical trials in ophthalmology. She is the PI on a UG1 grant, Descemet Endothelial Thickness Comparison Trial (DETECT), a randomized clinical trial comparing UT-DSAEK to DMEK and ripasudil versus placebo in patients with endothelial disease such as Fuchs Endothelial Dystrophy. She is also the PI on a UG1 grant, the Steroids and Cross-linking for Ulcer Treatment Trial (SCUT II), a randomized clinical trial in collaboration with Aravind Eye hospital in India looking at the benefit of adjunctive topical steroids, corneal crosslinking or rose bengal photodynamic therapy in the treatment of infectious ulcers.
As a native of Northern California, she loves spending time with her husband, three sons and Bernese Mountain Dog, Kenji, exploring California's natural beauty through hiking and camping.
